三七总苷注射液辅助治疗早期糖尿病肾病患者的疗效观察

目的观察三七总苷注射液辅助治疗早期糖尿病肾病患者的疗效。方法选择早期糖尿病肾病患者66例,随机分为治疗组和对照组,均给予饮食控制、降血脂治疗及控制血糖;治疗组则增加三七总苷注射液,15d为1疗程,共2个疗程,每个疗程间隔2d。同时观察比较治疗前后患者血、尿β2-微球蛋白(β2-MG),尿微量蛋白(Alb),尿蛋白(PRO)定量定性等指标的变化。结果治疗组总有效率(84.8%)优于对照组(63.6%)(P<0.05);此外,治疗组患者血β2-MG及尿β2-MG、Alb、PRO定量定性治疗前后均有明显下降且优于对照组;治疗过程中尚未发现副作用及严重的不良反应。结论三七总苷注射液可有效改善糖尿病肾病患者的肾功能。     

腹腔镜在女性不明原因急性右下腹痛诊治中的价值

目的 探讨腹腔镜在诊断和治疗女性不明原因急性右下腹痛中的价值。方法 回顾分析1999年4月～2004年4月52例女性不明原因急性右下腹痛的临床资料。结果 均在腹腔镜下明确诊断，急性阑尾炎28例，急性盆腔炎18例，卵巢囊肿蒂扭转3例，右输卵管妊娠2例，Crohn病致回肠穿孔1例。除3例中转开腹以外，余49例均在腹腔镜下完成手术。无并发症发生。腹腔镜术后2～6d出院。结论 腹腔镜是诊治女性不明原因急性右下腹痛及时、安全、有效的手段。     

电视胸腔镜辅助胸壁小切口肺叶切除术

目的比较电视胸腔镜辅助胸壁小切口与胸部单纯小切口肺叶切除术的临床效果. 方法 64例按手术先后顺序编号,按照随机数字表分为2组,电视胸腔镜辅助胸壁小切口(A组)和单纯小切口开胸手术(B组)进行肺叶切除术. 结果 A组切口长度(5.3±0.6)cm比 B组(8.9±0.5)cm显著缩短(t=-24.360,P=0.000);A组术中出血量(279.7±74.0)ml显著少于B组(331.7±42.5)ml(t=-3.330,P=0.002);A组手术当日引流量(162.5±47.4)ml显著少于B组(202.0±49.2)ml(t=-3.220,P=0.002);A组并发症5例,B组11例(χ2=4.099,P=0.043);A组术后住院(8.0±2.2)d显著短于B组(9.7±1.9)d(t=-3.280,P=0.002);2组手术时间无统计学差异(t=-1.130,P=0.262).57例随访6～12个月,术后6个月A组1例Ⅲa期鳞癌局部复发,B组2例Ⅲa期小细胞肺癌、1例腺癌术后7～8个月远处转移、局部复发,上述4例均于1年内死亡.3例死于与手术无关的其他疾病,余50例无局部复发、远处转移. 结论电视胸腔镜辅助胸壁小切口比单纯微创小切口进行肺叶切除术创伤小、并发症少、恢复快.     

腹腔镜下幽门环肌切开术治疗小儿先天性肥厚性幽门狭窄50例报告

目的总结腹腔镜下幽门环肌切开术治疗小儿先天性肥厚性幽门狭窄的成功经验.方法2001年4月～2004年4月,应用腹腔镜下幽门环肌切开术治疗小儿先天性肥厚性幽门狭窄50例,年龄12～90 d,平均35 d.分别在左、右上腹各置入3 mm trocar,左侧trocar置入无损伤抓钳夹近幽门处胃壁,右侧trocar先后置入伸缩式幽门肌切开刀、剥离器和幽门分离钳,完成幽门环肌切开术.结果腹腔镜下完成手术48例,中转开腹2例,其中1例为术中发现幽门前瓣膜症,1例为幽门黏膜损伤,经开腹修补痊愈.手术时间15～45 min,平均25 min.术后6 h拔胃管,开始喂奶.3～5 d出院.42例术后随访3～6个月,平均4.5月,生长发育均恢复正常.结论丰富的开腹手术经验、熟练的腹腔镜操作技术、术中良好的麻醉和合适的手术器械是完成腹腔镜下幽门环肌切开术的保障.     

吻合血管神经的(足母)展肌移植修复晚期面瘫

目的:探讨和研究治疗晚期面瘫的手术治疗,总结应用以足底内侧动静脉为蒂的(足母)展肌游离移植一期修复晚期面瘫40例效果和经验.方法:选取(足母)展肌为供肌,以足底内侧动静脉及其延续的胫后动静脉为血管蒂,以支配(足母)展肌神经及其延续的足底内侧神经和胫神经为神经蒂.(足母)展肌移植于患侧面部皮下,肌近断固定于口角,远端固定于耳前颧弓,血管神经蒂通过上唇皮下隧道与健侧面动静脉和面神经颊支吻合.结果:经随访一年以上,23例恢复了面部静态对称和理想的下面部随意和不随意运动;8例恢复了面部静态对称和部分下面部随意和不随意运动;9例仅恢复了面部静态对称.结论:(足母)展肌游离移植一期修复晚期面瘫具有疗效好、手术操作简便、肌肉大小适中、血管神经蒂走行位置恒定紧密伴行、血管神经蒂可切取较长、变跨面神经移植和肌肉移植的两期移植为一期移植等优点;而且,神经是血管化移植.     

Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells

Regeneration of sweat glands after deep burns has been an unsolved problem. Owing to lack of perspiration, survivors of an extensive deep burn injury are leading a miserable life in sultry months. It was our contemplation to solve this problem by inducing bone marrow mesenchymal stem cells (MSCs) to acquire the phenotype of sweat gland cells in vitro. Then these cells were transplanted into fresh skin wounds resulting from excision of anhydrotic scars after healing of deep burn injury in five patients. Two to 12 months after the procedure, it was proved that there was recovery of perspiration function in all the MSCs' transplanted areas, as evidenced by positive iodine–starch perspiration test. Histological and biochemical observation confirmed the involvement of MSCs transformed sweat gland cells in the recovery of functional sweat glands, and the components of sweat collected from these areas were similar to that collected from normal skin. This is the first report of successful transplantation of MSCs in regenerating functional sweat glands, which may help solve the problem of depletion of sweat glands in patients surviving extensive deep burns in the future.     

Total Arch Replacement with Stented Elephant Trunk Technique: A Proposed Treatment for Complicated Stanford Type B Aortic Dissection

Abstract   Objectives : The treatment of Stanford type B aortic dissections involving the arch or associated with proximal aortic aneurysms remains a surgical challenge. We report our results with total arch replacement with the stented elephant trunk (SET) procedure for these complicated Stanford type B aortic dissections. Methods: Between December 2003 and June 2008, 31 patients were admitted for complicated type B dissection (12 acute, 19 chronic). The mean age at operation was 44.3 ± 10.6 years (range: 22-68 years). The surgeries were performed by using total arch replacement combined with SET implantation. Enhanced computed tomography (CT) was performed before discharge as well as 3 months and annually to evaluate the condition of the graft and the residual false lumen. Results: The procedure was successful in all but two patients; two patients died of multiple organ failure following surgery. No paraplegia was observed after surgery. Follow-up was completed in 27 of 29 patients and the mean follow-up period was 18.4 ± 12.3 months (range: 6-54 months). During follow-up CT scans, thrombus formation was observed in the descending aortic false lumen excluded by the stented graft in most patients. One patient died during follow-up while two patients with Marfan syndrome underwent successful operations for replacement of the remaining descending and abdominal aorta. Conclusion: Total arch replacement with the SET procedure has emerged as a viable option for complicated type B dissections and is associated with low morbidity and mortality. At mid-term follow-up, most patients have either thrombosed or have had no further increase in the false lumen of the descending aorta.     

活动期感染性自然心内膜炎的外科治疗

目的　总结活动期感染性自然心内膜炎外科治疗的经验。方法　自 1996年 10月 1日至 2003年 12月 31日,阜外心血管病医院外科共手术治疗活动期感染性自然心内膜炎 54例。有明确感染诱因的 21例,先天性心内结构畸形 23例,风湿性瓣膜病 1例。术前心功能NYHA分级:Ⅰ级6例,Ⅱ级 12例,Ⅲ级 7例,Ⅳ级 29例。术前左心室舒张末径 ( 63±11 )mm。发病至手术间隔 8 ~629d(中位数 125d)。行主动脉瓣置换 25例,主动脉瓣及二尖瓣置换 15例,二尖瓣置换 6例,二尖瓣成形 3例,肺动脉瓣置换 1例,单纯心内分流修补 4例。术后应用足量敏感抗生素 6 ~8周。结果手术死亡 5例,死因均为感染,术后即失访 4例,手术死亡率 17% (9 /54)。14例 ( 26% )发生手术并发症。45例随访 6~67个月,平均(31±19)个月。术后心功能NYHA分级Ⅰ级 41例,Ⅱ级 3例,Ⅲ级 1例,左心室舒张末径 (52±8)mm。2例病人接受再次手术,术后康复;有再次手术指征但未手术者 3例。术后晚期意外死亡 1例,抗凝过量致颅内出血 1例。结论　活动期感染性自然心内膜炎经积极的外科治疗能够取得较好的治疗效果。     

主动脉成形术治疗主动脉瓣病变伴升主动脉扩张的疗效分析

目的总结主动脉成形术治疗主动脉瓣病变伴升主动脉扩张患者的临床经验及疗效。方法1998年2月至2004年5月共对23例主动脉瓣病变伴升主动脉扩张的患者行主动脉瓣膜置换和纵行切除部分升主动脉壁的主动脉成形术,术后随访4～78个月,平均(36±25)个月,分别于术前、术后出院前及术后随访中,通过心脏超声检查测量主动脉直径。结果主动脉直径术前为(4.8±0.5)cm,术后出院前为(3.6±0.4)cm,两者比较差异有统计学意义(P<0.01)。术后随访中,主动脉直径为(3.7±0.4)cm,与术前比较差异有统计学意义(P<0.01),与术后出院前比较差异无统计学意义(P>0.05)。结论应用切除部分升主动脉壁的主动脉成形术治疗主动脉瓣病变伴升主动脉扩张或升主动脉瘤,中期疗效良好。     

间质性膀胱炎的诊断和治疗探讨

目的探讨间质性膀胱炎的诊断与治疗。方法回顾性分析2002年7月—2004年6月诊治的10例间质性膀胱炎患者的临床资料。患者均为女性。平均年龄41岁;平均病程3.4年。符合美国国立糖尿病、消化和肾脏疾病学会间质性膀胱炎诊断标准。均行钾离子敏感试验,8例呈阳性反应。O′Leary Sant间质性膀胱炎症状评分9～20分,平均(14±4)分。所有病人首先行治疗性水扩张,1个月后评价疗效,对疗效不佳和水扩张后复发者行其他治疗。结果10例平均随访7.8个月。水扩张后1个月症状评分降至4～19分,平均(11±6)分,治疗前后比较,差异有统计学意义(t=4.394,P<0.05)。症状显著缓解2例,评分下降>7分;部分缓解3例,评分下降>3分。无效5例。有效率50%。结论钾离子敏感试验在间质性膀胱炎患者中有较高的阳性率。治疗性水扩张可作为首选的治疗方法。